Sounds like a simple packaging issue that could be resolved by sourcing an alternative medical fluid packaging. As long as the actual product inside the packaging is doing its job to break down the biofilms then I don't see it as a material issue for the company, I guess.
Charts NXS, page-849
Add NXS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
0.005(2.44%) |
Mkt cap ! $61.25M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 21.0¢ | 21.0¢ | $6.629K | 31.56K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2682 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.5¢ | 22139 | 5 |
View Market Depth
| Last trade - 11.21am 10/07/2024 (20 minute delay) ? |
| NXS (ASX) Chart |